☆ 4.8 Letter

Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus

CIRCULATION (2017)

Get Full Text
Add to Collection

Journal

CIRCULATION
Volume 136, Issue 12, Pages 1167-1169

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.117.029529

Keywords

central systolic pressure; empagliflozin; pulse wave analysis; SGLT-2 inhibitor; type 2 diabetes mellitus

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Funding

  1. Boehringer Ingelheim Pharma GmbH Co. KG

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.